Plain-English translation of NCT07205757 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether adding lidocaine โ a medication that protects the heart โ to Custodiol, a special solution used during bypass surgery, can reduce dangerous irregular heartbeats after surgery. Half the patients will receive standard surgery fluid, and half will receive the same fluid with the added medication mixed in. Both groups will have their heart rhythms carefully monitored to see if the medication makes a difference.
Irregular heartbeats are a common problem after bypass surgery and can be serious. Researchers want to see if this medication added to the surgical fluid might prevent these dangerous rhythms from developing in the first place.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will have standard pre-surgery tests including blood work, heart imaging, and an electrocardiogram. During your planned bypass surgery, you will randomly receive either the standard surgical fluid or the modified fluid with the added medication โ neither you nor your surgical team will know which one you received. After surgery, your heart rhythm will be monitored carefully to track any irregular heartbeats, and the research team will compare the results between the two groups.
AI-generated summary from trial data ยท Sep 18, 2026 ยท Not medical advice
Egypt